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Abstract 
Purpose: To investigate the mechanism by which pinitol inhibits tumor necrosis factor-α (TNF-α)-
induced expression of matrix metalloproteinase-9 (MMP-9) and invasion of prostate cancer LNCaP 
cells. 
Methods: Reverse transcription-polymerase chain reaction (RT-PCR) together with Western blot 
analysis was used to analyze the expression of MMP-9 and nuclear factor-κB (NF-κB) subunits, p65 
and p50, in TNF-α-treated LNCaP cells, while 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium 
bromide (MTT) assay, flow cytometry, and DNA fragmentation were used to evaluate cell viability and 
apoptosis. MMP-9 activity and invasion were measured by gelatin zymography and matrigel invasion 
assay, respectively. DNA-binding activity of NF-κB and AP-1 was determined by electrophoretic mobility 
shift assay and luciferase activity. 
Results: MMP-9 activity significantly increased in response to TNF-α; however, pinitol reduced TNF-α-
induced MMP-9 activity without cytotoxicity. Matrigel invasion assay showed that pinitol reduced TNF-α-
induced invasion of prostate cancer LNCaP cells. Further, it downregulated the expression of MMP-9 
gene induced by TNF-α-treatment. Pinitol suppressed TNF-α-induced NF-κB activity by suppressing 
nuclear translocation of the NF-κB subunits, p65 and p50. 
Conclusion: The results indicate that pinitol is a potential anti-invasive agent and acts by suppressing 
TNF-α-induced cancer cell invasion and specifically inhibiting NF-κB as well as downstream target 
genes such as MMP-9. 
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Matrix metalloproteinases (MMPs) are a family of 
zinc-dependent neutral endopeptidases that are 
collectively capable of degrading all components 
of the extracellular matrix. Degradation of the 
basement membrane and extracellular matrix by 
MMPs facilitates the invasion of malignant cells 
through connective tissues and blood vessel 
walls and results in the establishment of 
metastases [1]. Most MMPs are secreted as 
inactive zymogens and are extracellularly 
activated, where their functions are tightly 
regulated by several different mechanisms [2,3]. 
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MMP-9 contributes to invasion and metastasis, 
and is thought to be a key enzyme in the 
degradation of type IV collagen, which is a major 
component of the basement membrane [4] and is 
abundantly expressed in various malignant 
tumors including prostate, bladder, brain, liver, 
and pancreatic carcinoma [5]. Clinical 
investigations reveal that prostate cancer can 
metastasize to distant organs including the liver, 
bladder, bone, lungs, spine, and lymph nodes 
[6,7]. Therefore, a good strategy to treat prostate 
cancers is to target MMP-9 expression and 
activity. 
 
The transcription factor nuclear factor kappa-B 
(NF-κB) is involved in the regulation of several 
invasion-related genes such as MMP-9 in cancer 
cells [8]. NF-κB can act directly by binding to the 
MMP-9 promoter or indirectly via activation of 
other transcription factors. It has recently been 
reported that the inhibition of NF-κB activity 
decreases the tumorigenic and metastatic ability 
of human prostate cancer cells by suppressing 
angiogenesis and invasion through the 
downregulation of MMP-9 [9,10]. Therefore, 
targeting the NF-κB pathway is considered as a 
potential strategy to suppress MMP-9-mediated 
tumor invasion. 
 
Pinitol, traditionally used in Ayurvedic medicine 
and extracted from plants such as Bougainvillea 
spectabilis, has been shown to exhibit anti-
inflammatory and antidiabetic activities, inhibit 
the T-helper cell-1 response, and prevent 
cardiovascular diseases [11-13]. Pinitol appears 
to regulate the effects of insulin by targeting 
downstream in the insulin signaling pathway, 
suggesting that pinitol possesses hypoglycemic 
activity [14]. Pinitol also triggers apoptotic 
cascades in human breast cancer cells by 
inducing the expression of tumor suppressor 
genes [12]. However, little is known about the 
effects of pinitol on the expression and invasion 
of MMP-9 in prostate cancer cells. 
 
In this study, the effects of pinitol on MMP-9 
expression and invasion in TNF-α-stimulated 
prostate cancer LNCaP cells were evaluated. It 
was found that pinitol downregulated TNF-α-
induced MMP-9 expression and invasion by 




Reagent and antibodies 
 
Pinitol was purchased from Sigma Chemical Co. 
(St. Louis, MO) and dissolved in DMSO (vehicle). 
Antibodies against MMP-9, p65, p50, β-actin, 
and C23 were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA). MMP-9 inhibitor 
I (MMP-9-I) was obtained from Merck 
(Darmstadt, Germany). 3-(4,5-Dimethyl-2-
thiazolyl)-2,5-diphnyl-2H-tetrazolium bromide 
(MTT) and propidium iodine (PI) were obtained 
from Sigma Chemical Co. 
 
Cell culture and viability 
 
Human prostate cancer LNCaP cells were 
obtained from the American Type Culture 
Collection (Manassas, VA). Cells were 
maintained in RPMI medium (WelGENE Inc., 
Daegu, Republic of Korea) supplemented with 
10% heat-inactivated FBS (WelGENE Inc.) and 1 
% penicillin-streptomycin (WelGENE Inc.) in 5 % 
CO2 at 37 °C. Cells were seeded at 1 × 105 
cells/ml and then treated with various 
concentrations of pinitol. After 24-h incubation, 
the viability was determined by an MTT assay. 
 
Flow cytometric analysis 
 
Apoptotic sub-G1 phase was analyzed by PI-
stained cells. Briefly, LNCaP cells (1 × 106) were 
fixed in 70 % ethanol overnight at 4 °C. The cells 
were washed in phosphate-buffered saline (PBS) 
with 0.1 % BSA and incubated with 1 U/ml of 
RNase A (DNase free, Sigma) and 10 μg/ml of PI 
overnight at room temperature in the dark. The 
cells were analyzed using a FACSCalibur flow 
cytometer (Becton Dickenson, San Jose, CA). 
The levels of apoptotic cells with sub-G1 phase 
were determined as a percentage of the total 
number of cells. 
 
DNA fragmentation assay 
 
LNCaP cells were treated with the indicated 
chemicals and then lysed on ice in a lysis buffer 
containing 10 mM Tris-HCl (pH 7.4), 150 mM 
NaCl, 5 mM EDTA, and 0.5 % Triton X-100 for 
30 min. Lysates were vortexed and cleared by 
centrifugation at 10,000 g for 20 min. 
Fragmented DNA in the supernatant was 
extracted with an equal volume of neutral 
phenol:chloroform:isoamylalcohol (25:24:1, v/v/v) 
and electrophoretically analyzed on a 1.5 % 
agarose gel containing ethidium bromide. 
 
Wound healing assay 
 
LNCaP cells were grown to 90 % confluence in a 
6-well plate in 5 % CO2 at 37 °C. A wound was 
created by scratching cells with a sterile 200 μl 
pipette tip. The cells were washed twice with 
PBS to remove floating cells and then added to a 
medium without serum for 24 h. Images of the 
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Cultured LNCaP cells were harvested and 
washed with serum-free RPMI medium three 
times, and incubated for 24 h at 5 × 105 cells/ml 
in serum-free RPMI medium (conditioned 
medium). The cells were administrated with 
pinitol in the presence or absence of TNF-α. 
MMP-9 activity was determined by gelatin 
zymography using 0.1 % gelatin as a substrate. 
The conditioned medium was mixed with SDS-
PAGE sample buffer in the absence of reducing 
agent and electrophoresed in 8 % 
polyacrylamide gel. After electrophoresis, the 
gels were washed three times with 2.5 % Triton 
X-100 in water and then incubated overnight in a 
closed container at 37 °C in 0.2 % Brij 35.5 mM 
CaCl2, 1 mM NaCl, and 50 mM Tris (pH 7.4). The 
gels were stained for 30 min with 0.25 % 
Coomassie Blue in 10 % acetic acid and 45 % 
methanol, and then destained for 30 min using 
an aqueous mixture with 20 % acetic acid, 20 % 
methanol, and 17 % ethanol. Areas of protease 
activity appeared as clear bands. 
 
Western blot analysis 
 
Total cell extracts were prepared using PRO-
PREP protein extraction solution (iNtRON 
Biotechnology, Sungnam, Republic of Korea). 
Proteins were separated by SDS-PAGE and 
electrotransferred to nitrocellulose membranes 
(Amersham, Arlington Heights, IL). The detection 
of specific proteins was carried out with an ECL 
Western blotting kit (Amersham) according to the 
recommended procedure. 
 
RNA extraction and RT-PCR 
 
Total RNA was isolated using Trizol reagent 
(GIBCO-BRL, Gaithersburg, MD) according to 
the manufacturer′s recommendations. Genes of 
interest were amplified from cDNA that was 
reverse-transcribed from 1 μg of total RNA using 
the One-Step RT-PCR Premix (iNtRON 
Biotechnology). Primers for MMP-9 sense (5′- 
CCT GGA GAC CTG AGA ACC AAT CT-3′); 
MMP-9 antisense (5′-CCA CCC GAG TGT AAC 
CAT AGC-3′); and glyceraldehydes-3-phosphate 
dehydrogenase (GAPDH) sense (5′-CCA CCC 
ATG GCA AAT TCC ATG GCA-3′); GAPDH 
antisense (5′-TCT AGA CGG CAG GTC AGG 
TCC ACC-3′) were used. PCR reaction was 
initiated at 94 ºC for 2 min followed by 31 cycles 
of 94 ºC for 30 min, 30-min annealing 
temperature, 72 ºC for 30 min followed by final 
extension at 72 ºC for 5 min. Annealing 
temperatures for MMP-9 and GAPDH were 63 ºC 
and 62 ºC, respectively. After amplification, PCR 
products were separated on 1.5 % agarose gels 




Invasion assays were performed using modified 
Boyden chambers with polycarbonate 
nucleopore membrane (Corning, Corning, NY). 
Precoated filters (6.5 mm in diameter, 8 μm pore-
size, Matrigel 100 μg/cm2) were rehydrated and 
5 × 104 cells in medium with or without pinitol or 
MMP-9 inhibitor I (5 nM) in the presence or 
absence of TNF-α (20 ng/ml) were seeded into 
the upper part of each chamber. After 24-h 
incubation, nonmigratory cells on the upper 
surface of the filter were wiped with a cotton 
swab and migrated cells on the lower surface of 
the filter were fixed and stained with 0.125 % 
Commassie Blue in a methanol:acetic acid:water 
mixture (45:10:45, v/v/v). Random fields were 




NF-κB and AP-1 reporter construct were 
purchased from Clontech (Palo Alto, CA). Briefly, 
LNCaP cells were plated onto six-well plates at a 
density of 5 × 105 cells/well and grown overnight. 
Cells were transfected with 2 μg of each plasmid 
construct for 6 h by the Lipofectamine method. 
After transfection, the cells were cultured in 10 % 
FBS containing RPMI medium with various 
concentrations of pinitol in the presence of 20 
ng/ml TNF-α for 24 h. Cells were lysed with lysis 
buffer (20 mM Tris-HCl, pH 7.8, 1 % Triton X-
100, 150 mM NaCl, and 2 mM DTT). Five μl of 
cell lysate was mixed with luciferase 25 μl activity 
assay reagent and luminescence produced for 5 
s was measured using GLOMAX luminometer 
(Promega, Madison, WI). 
 
Electrophoretic mobility shift assay (EMSA) 
 
The preparation of cytoplasmic and nuclear 
extracts was conducted using the NE-PER 
nuclear and cytoplasmic extraction reagents 
(Pierce, Rockford, IL). DNA-protein binding 
assays were carried out with nuclear extract. 
Synthetic complementary NF-κB-binding 
oligonucleotides (5′-AGT TGA GGG GAC TTT 
CCC AGG C-3′) (Santa Cruz Biotechnology) 
were biotinylated using the biotin 30-end DNA 
labeling kit (Pierce) according to the 
manufacturer′s instructions and annealed for 1 h 
at room temperature. Binding reactions were 
carried out for 20 min at room temperature in the 
presence of 50 ng/ml poly(dI-dC), 0.05 % 
Nonidet P-40, 5 mM MgCl2, 10 mM EDTA, and 
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2.5 % glycerol in 1× binding buffer (LightShiftTM 
chemiluminescent EMSA kit) with 20 fmol of 
biotin-end-labeled target DNA and 10 μg of 
nuclear extract. Assays were loaded onto native 
4 % polyacrylamide gels pre-electrophoresed for 
60 min in 0.5x Tris borate/EDTA and before 
being transferred onto a positively charged nylon 
membrane (HybondTM-N+) in 0.5x Tris 
borate/EDTA at 100 V for 30 min. Transferred 
DNAs were cross-linked to the membrane at 120 
mJ/cm2 and detected using horseradish 
peroxidase-conjugated streptavidin according to 




The images were visualized with Chemi-Smart 
2000 (Vilber Lourmat, Cedex, France). Images 
were captured using Chemi-Capt (Vilber 
Lourmat) and transported into Adobe Photoshop 
(version 8.0). All data are presented as mean ± 
SE. Significant differences between the groups 
were determined using one-way ANOVA test. P 





Pinitol has no effect on LNCaP cell viability 
with inhibition of migration 
 
In order to determine the cytotoxic potential of 
pinitol in LNCaP cells, an MTT assay was 
performed 24 h after treatment with the indicated 
concentrations of pinitol in the presence of FBS. 
Pinitol with and without TNF-α was not cytotoxic 
at any of the concentrations tested in the study 
(Fig 1A). DNA fragmentation was analyzed and it 
was observed that neither pinitol nor pinitol with 
TNF-α-treated groups showed fragmented DNA 
compared with the positive H2O2-treated group 
(Fig 1B). Therefore, pinitol levels below 400 μM 
were selected for subsequent experiments. 
 
The effects of pinitol on cell viability and 
cytotoxicity were analyzed in detail. According to 
the percentages of sub-G1 DNA contents by flow 
cytometry, there was no apoptotic cell death in 
either panel compared to the positive H2O2-
treated group (Fig 1C). Additionally, to determine 
whether pinitol inhibits TNF-α-induced migration, 
a scratch wound healing assay was carried out. 
Cell migration was significantly increased by 
TNF-α treatment and the effects were inhibited in 
the presence of pinitol (Fig 1D). Taken together, 
these data indicate that pinitol inhibits TNF-α-
induced migration, and that the acquisition of 
migration is related to tumor invasion without 
cytotoxicity. 
 
Pinitol suppresses TNF-α-induced MMP-9 
expression and invasion of LNCaP cells 
 
Zymography, RT-PCR, and a western blot 
analysis were conducted to assess whether 
pinitol regulates MMP-9 expression and activity. 
The zymography data showed that treatment 
with TNF-α significantly increased gelatin 
degradation of MMP-9 in LNCaP cells; however, 
pinitol suppressed TNF-α-induced MMP-9 
activity (Fig 2A). Further, because zymography 
was performed under serum-free conditions, an 
MTT assay was performed 24 h after treatment 
with the indicated concentrations of pinitol in the 
absence of FBS. 
 
Pinitol with or without TNF-α was not cytotoxic at 
any of the concentrations tested in this study (Fig 
2B). It was also found that pinitol downregulated 
TNF-α-induced MMP-9 mRNA and protein 
expression. In the western blot analysis, TNF-α 
stimulation of the cells resulted in a significant 
increase in MMP-9 expression compared to that 
in the untreated control; however, pinitol reduced 
TNF-α-induced MMP-9 expression to the levels 
of the untreated control (Fig 2C). Moreover, 
MMP-9 gene expression was confirmed by RT-
PCR analysis. Pretreatment with pinitol 
significantly suppressed TNF-α-induced MMP-9 
upregulation at the mRNA level (Fig 2D). Taken 
together, these results indicate that pinitol 
suppresses TNF-α-stimulated MMP-9 expression 
at the transcriptional level. 
 
MMP-9 is thought to be significantly involved in 
the processes of tumor invasion and 
angiogenesis. Since pinitol inhibited MMP-9 
expression and activity, the effects of pinitol on 
invasion of LNCaP cells were examined. When 
the cells were treated with TNF-α alone, a 
remarkable 4-fold increase in cell invasion was 
observed compared to that in the untreated 
control (Fig 2E). However, pinitol pretreatment 
resulted in 50 % reduction in TNF-α-induced 
penetration through a matrigel-coated membrane 
compared to that in the TNF-α-treated group (Fig 
2E). These results confirm that pinitol inhibits 
TNF-α-induced invasion of prostate cancer 
LNCaP cells. 
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Fig 1: Effect of pinitol on the viability of LNCaP cells. LNCaP cells were treated with the indicated concentrations 
(0 - 400 μM) of pinitol and/or 20 ng/ml TNF-α in the presence of FBS for 24 h. (A) Cell viability was measured by 
an MTT assay. (B) Total DNA was extracted from the treated cells and the DNA fragmentation assay was 
analyzed on a 1.5 % agarose gel. (C) DNA content was analyzed by flow cytometry. The percentage of sub-G1 
DNA content is indicated in each panel. The data and arrow in the figure indicate the percentage of each sub-G1 
phase in the cell cycle distribution. (D) For the wound healing assay, cells were treated with pinitol in the 
presence or absence of 20 ng/ml TNF-α in a six-well plate and incubated for 24 h. Images of the wound were 
taken under a microscope at 100 magnitude 
 
Pinitol downregulates TNF-α-induced NF-κB 
activity, not AP-1 
 
In order to determine whether MMP-9 mRNA 
expression was regulated by NF-κB or AP-1 
activity, a promoter assay was carried out using 
transiently transfected LNCaP cells with a 
luciferase reporter vector that included the NF-κB 
or AP-1 binding sites. NF-κB luciferase activity 
increased approximately 10-fold in TNF-α-treated 
LNCaP cells compared to that in the untreated 
control group (Fig 3A). TNF-α-stimulated 
luciferase activity in the cells containing the NF-
κB construct was significantly reduced by 
treatment with pinitol. However, no significant 
change in AP-1 luciferase level was observed in 
response to pinitol or TNF-α, suggesting that 
pinitol regulates TNF-α-induced MMP-9 
expression independently of AP-1. 
 
The specific DNA-binding activity of NF-κB was 
assessed by EMSA to investigate whether pinitol 
inhibited MMP-9 activity by suppressing NF-κB. 
TNF-α-stimulation caused a remarkable increase 
in binding complexes between NF-κB and 
specific-binding DNA at 30 min; pretreatment 
with pinitol significantly reduced TNF-α-induced 
NF-κB activity (Fig 3B). 
 
In a similar experiment, expression levels of p65 
and p50 in the cytoplasmic region were 
determined after TNF-α-stimulation. TNF-α 
significantly lowered p50 and p65 expression in 
the cytoplasmic compartments of LNCaP cells; 
however, treatment with pinitol sustained the 
TNF-α-induced expression of p50 and p65 (Fig 
3C). Treatment with pinitol also attenuated TNF-
α-induced nuclear translocation of p50 and p65. 
These results indicate that pinitol inhibits MMP-9 





Based tumor invasion and metastasis are 
multistep processes by which a subset of 
individual cancer cells disseminate from a 
primary tumor to distant secondary organs or 
tissues. MMPs play a major role in promoting 
tumor invasion and metastasis; MMP-9, in 
particular, is regarded as a critical molecule in 
regulating the progression of tumor invasion and 
metastasis [15]. Thus, the inhibition of MMP-9  
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Fig 2: Effects of pinitol on TNF-α-induced MMP-9 expression and invasion of LNCaP cells. (A) LNCaP cells were 
treated with 400 μM pinitol 1 h before treatment with 20 ng/ml TNF-α in the absence of FBS for 24 h. Conditioned 
medium was collected, and subjected to gelatin zymography. (B) Cell viability was measured in the absence of 
FBS by an MTT assay at 24 h. (C) Equal amounts of cell lysates were resolved on SDS-polyacrylamide gels, 
transferred to nitrocellulose membranes, and probed with antibodies against MMP-9. (D) LNCaP cells were 
incubated with the indicated concentrations of pinitol 1 h before treatment with 20 ng/ml TNF-α for 6 h. Total RNA 
was isolated, and RT-PCR analysis of MMP-9 was performed. (E) The upper part of the transwells was coated 
with matrigel for the invasion assay. The cells were then cultured in serum-free media for 3 h before treatment 
with 400 μM pinitol in the absence or presence of 20 ng/ml TNF-α. After 24-h incubation, the cells passing 
through the matrigel to the membrane were dyed using 0.125 % Coomassie Blue in ethanol. Statistical 
significance was determined by a one-way ANOVA test (*, p < 0.05 vs. TNF-α-treated group). Note: GAPDH and 
β-actin were used as internal controls for the RT-PCR and western blot analysis, respectively. MMP-9-I = MMP-9 
inhibitor 
 
expression is an important therapeutic 
experimental model of tumor invasion. The 
results demonstrate that pretreatment with pinitol 
inhibits TNF-α-induced MMP-9 activity 
accompanied by suppression of MMP-9 gene 
transcription in prostate cancer LNCaP cells. 
Additionally, the matrigel assay shows that pinitol 
suppresses TNF-α-induced invasion of LNCaP 
cells. 
 
Although NF-κB plays a key role in regulating the 
immune response to infection, aberrant or 
incorrect regulation of NF-κB has been linked to 
improper inflammatory immune responses. 
Several studies have also identified the signal 
transduction pathways involved in regulating 
MMP-9 expression in various cells [16,17]. In 
particular, NF-κB is an important transcription 
factor for regulating the MMP-9 gene expression 
containing NF-κB binding sites [8]. In response to 
stimuli, IκB is phosphorylated and degraded, and 
NF-κB is released and subsequently translocated 
to the nucleus [18]. 
 
Since expression of the MMP-9 gene is regulated 
at the transcriptional level by the NF-κB/Rel 
family of transcription factors [17], the expression 
of p65 and p50 was tested, as well as the 
specific DNA-binding activity of NF-κB. In this 
study, it was shown that pinitol regulates the NF-
κB activity by inhibiting p65 and p50 protein 
translocation. The results suggest that the 
downregulation of NF-κB by pinitol could 
potentiate anti-invasive activities via the 
downregulation of MMP-9 expression. Further, it 
was shown that the TNF-α-stimulated luciferase 
activities in LNCaP cells were significantly 
reduced in response to pinitol. 
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Fig 3: Effects of pinitol on NF-κB-DNA binding activity. LNCaP cells were treated with 400 μM pinitol in the 
presence of 20 ng/ml TNF-α. (A) Cells were transfected with WT-NF-κB and AP-1 promoter-containing reporter 
vectors, and luciferase activity was measured 24 h after transfection. Cells were preincubated with 400 μM pinitol 
1 h before treatment with 20 ng/ml TNF-α for 9 h. (B) Nuclear extracts were assayed for NF-κB activity by EMSA 
at 30 min and (C) the levels of p50 and p65 were analyzed by western blot analysis. Statistical significance was 
determined by a one-way ANOVA test (*, p < 0.05 vs. TNF-α-treated group). Note: β-Actin and C23 were used 
as an internal control for the western blot analysis 
 
It has been reported that several transcription 
factors in the human MMP-9 promoter region 
such as AP-1 and SP1, also regulate MMP-9 
expression in response to lipopolysaccharide, 
phorbol 12-myristate 13-acetate (PMA), and 
TNF-α [19,20]. The AP-1 site at approximately 
−70 bp upstream of the transcriptional start site 
has long been thought to play a dominant role in 
the transcriptional activation of the MMP 
promoters in response to PMA [21]; however, 
pinitol could not regulate TNF-α-stimulated AP-1 
activity in this study. The role of SP1 in regulating 
expression of MMP-9 has not been determined in 
this study, although SP1 sites of the MMP-9 
promoter are important transcriptional elements 
[22]. Therefore, further experiments are needed 
to confirm the role of SP1 in regulation of TNF-α-




Findings from this study suggest that treatment 
with pinitol plays an important role in the 
regulation of MMP-9, resulting in the inhibition of 
invasion of prostate cancer LNCaP cells. The 
results also show that pinitol is a potent inhibitor 
of TNF-α-induced MMP-9 expression and 
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